Signaling through insulin/insulin-like growth factor (IGF) guides the development of the cells that give rise to the gonad and adrenal cortex in mice, according to a new report.
The mammalian gonads and adrenal cortex develop from a common structure in the early embryo, the adreno-genital primordium (AGP). The AGP then produces the gonadal primordium, which has the potential to differentiate into either testes or ovaries. Proper gonadal differentiation requires steroidogenic factor 1 (SF1, a.k.a. NR5A1), a nuclear receptor expressed in the AGP and gonadal primordium. SF1 operates with the Y chromosome-encoded protein SRY to promote differentiation of the testis. In the absence of SRY activity, the ovarian differentiation program dominates.
A previous study by Serge Nef and colleagues showed that signaling through insulin/IGF is required for testis determination, but it was unclear whether insulin/IGF had its impact on cell fate decisions at the stage of testis determination or earlier during the period of formation of the AGP.
The new findings show that insulin/IGF signaling affects the development of the AGP and likely the gonadal primordium as well. The researchers examined mice mutant for both the IGF type I receptor (Igf1r) and the insulin receptor (Insr). The mice failed to develop an adrenal cortex and also showed complete embryonic XY gonadal sex reversal caused by a delay of Sry upregulation and subsequent failure of the testicular genetic program. Both XY and XX mice ultimately developed ovaries.
The double-mutant mice had a reduced number of SF1-expressing cells and the cells that expressed SF1 did so at reduced levels, a finding that may explain the dysregulation of Sry. The geneexpression program in the somatic progenitor cells to the gonad was also affected in the knockout mice. Previous studies have suggested that these progenitors express a battery of genes that are found in both gonads before committing to the male or female fate. The new study showed a similar pattern and provided compelling evidence that this program was disrupted in the double mutant.
The new study places insulin/IGF signaling as one of the earliest known events in the differentiation of the gonads and adrenal cortex, a finding in line with previous work showing that insulin/IGF can regulate cell proliferation, differentiation, metabolism, and cell survival in numerous physiological contexts. Two new studies show how dysregulation of the immune system in the uterus can lead to spontaneous abortion.
The first study examined a key immune cell during pregnancy, the natural killer (NK) T cell, and showed how it shields the fetus-with its host of foreign antigens-from immune attack by the mother. NK cells are the most abundant immune cell at the maternal-fetal interface and have been implicated in a range of activities, from promoting growth of blood vessels to prompting the activity of regulatory T cells, which are known to quell immunity. In experiments in mice and human cells, Binqing Fu et al. have added another function to the list.
The researchers honed in on a type of NK cell that predominates during the first trimester, CD56 bright CD27 þ , and found that these cells counter the activity of pro-inflammatory Th17 cells. It seems that IFNG and other molecules released by NK cells quell Th17 cells that recognize fetal antigens. Human NK cells, for instance, inhibited the development of Th17 cells in culture and IFNG antibody blocked this activity. Moreover, deletion of NK cells in pregnant mice resulted in an increase in the number of Th17 cells, accompanied by an apparent increase in fetal loss.
The researchers also obtained decidual tissues from women with recurrent spontaneous abortions. The NK cells in these tissues did not function properly and there were fewer of them. The impaired NK cells did not adequately dampen Th17 cells, which were present at elevated levels in the decidua. The researchers speculate that severe inflammation, such as that caused by a viral infection or autoimmune disorder, could lead to dysregulation of NK cells and spontaneous abortion. The new findings also increase the understanding of how immune tolerance develops at the maternal-fetal interface, protecting the fetus from destruction by the immune system.
The second study took a different approach to show how an imbalance between anti-and pro-inflammatory mediators may also lead to spontaneous abortion. The research followed up on studies suggesting that the decidualized endometrium can recognize abnormal embryos and examined how the immune system is altered as the endometrium becomes receptive to an implanting blastocyst.
During the window of implantation, the endometrium is in a proinflammatory state, which switches to an anti-inflammatory state as the window closes. Madhuri Salker et al. found that during the proinflammatory state, cells in the endometrium release the proinflammatory mediator IL-33, which is subsequently downregulated by the expression of a decoy receptor. Women with spontaneous abortions showed defects in the timing of expression of the decoy receptor and had a longer window of implantation, possibly allowing for implantation of defective or slow-growing embryos that later abort. Germ cells are notoriously difficult to study during embryonic development due to the large number of them required for molecular biology experiments. Jia-Hui Ng et al. have downsized a procedure for examining epigenetic modifications and applied it to mouse germ cells, producing data that begin to demonstrate how dynamic changes in DNA regulation usher these cells through development in the embryo.
To obtain material, the researchers did a fluorescence-activated cell sorting (FACs) analysis on cells from mouse embryos and pulled out germ cells that were marked by a GFP-expressing transgene. They then went on to do a modified version of chromatin immunoprecipitation sequencing (ChIP-seq), a procedure for analyzing modifications such as histone acetylation and methylation.
The new protocol could work on fewer than 100,000 germ cells, which the researchers could obtain from about 20 embryos. In comparison, conventional ChIP-seq generally requires between 5 million and 20 million cells.
The researchers generated genome-wide maps of four histone modifications and traced how the modifications change in the embryo as the germ cells transition from an immature state and begin the early stages of differentiation. Several patterns emerged, but two seemed to stand out.
A binding motif for the nuclear receptor Nr5a2 was enriched at the regulatory regions of a subset of genes expressed in germ cells. The researchers also identified an important role for the H3K27me3 histone modification, which is generally associated with repression. They found that this modification occurred more frequently in regions enriched for retrotransposons, suggesting that these loci are specifically silenced in germ stem cells. This silencing might provide a mechanism to keep such genes repressed during a developmental period when much of the DNA itself is stripped of repressive methyl marks. H3k27me3 was also enriched at regions regulating major histocompatibility complex (MHC), hinting at a mechanism to help sperm evade an attack by the immune system.
The new technique will be useful for future studies of germ cells and other aspects of development. A DNA test that piggybacks onto a routine clinical procedure, the pap smear, may one day be used to detect ovarian and endometrial cancers. A pilot study of the approach was able to detect 100 percent of endometrial cancers and 41 percent of ovarian cancers tested-with no false positives.
The pap smear first emerged from a seminal study in 1943 by Georgios Papanicolaou entitled, ''Diagnosis of Uterine Cancer by the Vaginal Smear.'' Since then, the life-saving procedure to detect cervical cancer has become routine and, in recent years, the collection of DNA was added to test for human papillomavirus, which is associated with the disease. In a new study, Isaac Kinde et al. proposed that DNA samples from the cervix could also include DNA from cells sloughed off of endometrial or ovarian tumors.
The authors began by assembling information on common mutations known to be associated with these cancers and provided new data on mutations associated with the most common type of endometrial cancers. They then tested 46 samples from patients with endometrial or ovarian cancers and confirmed that all 46 tumors contained at least some of the mutations on their list.
They then asked if these tumors could be detected in DNA samples obtained from routinely collected PAP smears by using PCR combined with a specialized form of next generation sequencing. Their method successfully identified 100 percent of 24 endometrial cancers, and 41 percent of 22 ovarian cancers.
The researchers also generated a test for screening purposes called PapGene, which assessed a panel of 12 genes. The test was able to detect ovarian and endometrial cancers in 14 patients who had mutant allele fractions above the level of detection of the assay (.0.1 percent). No mutations were detected in the 14 pap specimens from women without cancer.
Additional, larger studies are needed to determine the efficacy of the method and to verify that the test has a low false-positive rate. It is possible that modifications to the procedure, such as testing for additional mutations or changing how the sample is collected, could increase the sensitivity of detection for ovarian cancer.
